ReNerve (ASX:RNV) signed an exclusive distribution partnership agreement with Imbiomex to progress its nerve repair biomaterial product, NervAlign Nerve Cuff, in
Mexico, according to a Thursday Australian bourse filing.
The two companies have now started the regulatory application process to achieve market approval for the product, following which Imbiomex will market and sell the product in Mexico, the filing added.
The company's shares were down nearly 5% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.